224 related articles for article (PubMed ID: 23688135)
1. CYP epoxygenase derived EETs: from cardiovascular protection to human cancer therapy.
Chen C; Wang DW
Curr Top Med Chem; 2013; 13(12):1454-69. PubMed ID: 23688135
[TBL] [Abstract][Full Text] [Related]
2. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
Xu X; Zhang XA; Wang DW
Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450-CYP2 Family-Epoxygenase Role in Inflammation and Cancer.
Chen C; Wang DW
Adv Pharmacol; 2015; 74():193-221. PubMed ID: 26233908
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice.
Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Nayeem MA
PLoS One; 2017; 12(3):e0174137. PubMed ID: 28328948
[TBL] [Abstract][Full Text] [Related]
5. EET signaling in cancer.
Panigrahy D; Greene ER; Pozzi A; Wang DW; Zeldin DC
Cancer Metastasis Rev; 2011 Dec; 30(3-4):525-40. PubMed ID: 22009066
[TBL] [Abstract][Full Text] [Related]
6. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.
Shahabi P; Siest G; Visvikis-siest S
Drug Metab Rev; 2014 Feb; 46(1):33-56. PubMed ID: 24040964
[TBL] [Abstract][Full Text] [Related]
7. Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders.
Shahabi P; Siest G; Meyer UA; Visvikis-Siest S
Pharmacol Ther; 2014 Nov; 144(2):134-61. PubMed ID: 24882266
[TBL] [Abstract][Full Text] [Related]
8. Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury.
Nithipatikom K; Moore JM; Isbell MA; Falck JR; Gross GJ
Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H537-42. PubMed ID: 16473964
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic and free radical formation of cis- and trans- epoxyeicosatrienoic acids in vitro and in vivo.
Aliwarga T; Raccor BS; Lemaitre RN; Sotoodehnia N; Gharib SA; Xu L; Totah RA
Free Radic Biol Med; 2017 Nov; 112():131-140. PubMed ID: 28734877
[TBL] [Abstract][Full Text] [Related]
10. CYP2J2 and EETs Protect against Oxidative Stress and Apoptosis in Vivo and in Vitro Following Lung Ischemia/Reperfusion.
Chen W; Zheng G; Yang S; Ping W; Fu X; Zhang N; Wang DW; Wang J
Cell Physiol Biochem; 2014; 33(6):1663-80. PubMed ID: 24903033
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation.
Deng Y; Theken KN; Lee CR
J Mol Cell Cardiol; 2010 Feb; 48(2):331-41. PubMed ID: 19891972
[TBL] [Abstract][Full Text] [Related]
12. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.
Spiecker M; Liao JK
Arch Biochem Biophys; 2005 Jan; 433(2):413-20. PubMed ID: 15581597
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo.
Chen C; Li G; Liao W; Wu J; Liu L; Ma D; Zhou J; Elbekai RH; Edin ML; Zeldin DC; Wang DW
J Pharmacol Exp Ther; 2009 Jun; 329(3):908-18. PubMed ID: 19289568
[TBL] [Abstract][Full Text] [Related]
14. The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling.
Fleming I
Vascul Pharmacol; 2016 Nov; 86():31-40. PubMed ID: 26975734
[TBL] [Abstract][Full Text] [Related]
15. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response.
Nayeem MA; Geldenhuys WJ; Hanif A
Adv Pharmacol; 2023; 97():37-131. PubMed ID: 37236764
[TBL] [Abstract][Full Text] [Related]
16. CYP2J2-Derived EETs Attenuated Angiotensin II-Induced Adventitial Remodeling via Reduced Inflammatory Response.
Zhou C; Huang J; Chen J; Lai J; Zhu F; Xu X; Wang DW
Cell Physiol Biochem; 2016; 39(2):721-39. PubMed ID: 27459385
[TBL] [Abstract][Full Text] [Related]
17. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.
Imig JD
Adv Pharmacol; 2016; 77():105-41. PubMed ID: 27451096
[TBL] [Abstract][Full Text] [Related]
18. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.
Chen G; Xu R; Zhang S; Wang Y; Wang P; Edin ML; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2015 Jan; 308(2):E97-E110. PubMed ID: 25389366
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids.
Sun J; Sui X; Bradbury JA; Zeldin DC; Conte MS; Liao JK
Circ Res; 2002 May; 90(9):1020-7. PubMed ID: 12016269
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of amyloid β on the cytochrome P450 epoxygenase activity in rat brain.
Sarkar P; Narayanan J; Harder DR
Neuroscience; 2011 Oct; 194():241-9. PubMed ID: 21843605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
